Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules.
about
Mouse models of hepatitis B virus infection comprising host-virus immunologic interactionsAn AAV vector-mediated gene delivery approach facilitates reconstitution of functional human CD8+ T cells in miceAdeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in MiceClearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic VaccinationA Novel Hydrodynamic Injection Mouse Model of HBV Genotype C for the Study of HBV Biology and the Anti-Viral Activity of Lamivudine.In vivo models of hepatitis B and C virus infection.Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation.Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma.Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.A mouse model for HBV immunotolerance and immunotherapy.Hepatitis C virus infection and related liver disease: the quest for the best animal modelMouse models for therapeutic vaccination against hepatitis B virus.Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.Gender disparity in chronic hepatitis B: Mechanisms of sex hormones.Modeling hepatitis B virus infection, immunopathology and therapy in mice.Mouse Models of Hepatitis B Virus PathogenesisRecombinant cccDNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model.Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice.Viral hepatitis: The bumpy road to animal models for HBV infection.TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy.Nanovaccine for immunotherapy and reduced hepatitis-B virus in humanized model.Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance.A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model.Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo.Mouse models for hepatitis B virus researchClearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvant
P2860
Q27002598-CB3D22F0-00DF-402F-BF6A-63AA1D80E757Q35091621-752FFA46-6E68-4294-B45C-A8C603F2BF2EQ35663840-E5F7AD8C-E072-4DED-B8E4-7A01DB3C144FQ36776755-2EB14A76-0CF2-4AD6-B80C-2C796227E895Q36902603-6E30975A-CA1C-46DE-B912-800DA52D00B4Q37095706-F4190E73-21FC-4F39-84D9-5F091620ACF4Q37135201-27282613-70EF-4AF6-BBDB-2301D06ABEC3Q37415360-8DB04B23-F98A-4F09-81FF-49996D1DF4D6Q37644059-471AF687-C6F0-4EAE-9BDF-00A8EDBB315CQ37727712-453BD2E8-7CAA-4F78-B8C9-47E8D529FFB0Q38125192-EC6791D8-75A0-44C3-A5B6-5D923456034AQ38293590-11F6E50F-5852-4B33-B461-A594212E396BQ38351585-F1D34540-9ACF-4F7C-9F5C-90ABFA4BFD8AQ38357110-C6A53723-F755-47BE-BA49-DD6C8152FC8BQ38364526-8A9AAF93-A9E3-435C-A827-7924441323F2Q38534533-44E193F1-22FD-4195-89E6-4002BE708659Q38570421-C5E27A83-D6C8-4A46-A8DD-8BD767DD6B40Q40106034-C58E996D-F5A1-4139-BA42-4AAF1C6F9EFDQ40226732-C7EDD486-28D6-4289-9937-B7C945919679Q40246829-344A827B-A2DE-442E-95C3-3398D1B45F8FQ41646089-D10BC9D2-349A-463E-B7E1-2F6E6408C3F1Q41919495-2DB9142B-1FDB-445E-AD6E-F861F5E140EEQ45324194-8FC5B93B-1C2B-4F2A-BC57-41F9CBE22A87Q47117235-1311687C-FEC4-46EB-BD25-D2CFCDE4E809Q47547227-73C38111-EE3E-49E2-9945-6CE1F176D9B5Q55398183-D9A32574-C147-4A49-A62B-B43778A619A8Q57494795-992F8974-7FF7-423E-882D-A8EFE2B77FFCQ57824837-ECB0E343-82C4-4331-BE4D-47DE93971773
P2860
Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Adeno-associated virus-mediate ...... HLA-A2 and HLA-DR1 molecules.
@en
type
label
Adeno-associated virus-mediate ...... HLA-A2 and HLA-DR1 molecules.
@en
prefLabel
Adeno-associated virus-mediate ...... HLA-A2 and HLA-DR1 molecules.
@en
P2093
P2860
P356
P1433
P1476
Adeno-associated virus-mediate ...... HLA-A2 and HLA-DR1 molecules.
@en
P2093
Florence Levillayer
Marie-Louise Michel
Ophélie Godon
P2860
P304
P356
10.1128/JVI.03134-12
P407
P577
2013-03-06T00:00:00Z